colloidal Silver?

Hello All! This is my first time posting, but I am desperately trying to find information about colloidal silver. There is some talk bubbling up among my Cf community about nebulizing colloidal silver, so I wanted to get a feel for it from y'all. I've been trying to find research on the issue but all I can come up with is claims by the actual companies selling the product. I will admit I am very skeptical, so this post will reflect my fear. Please know I am not trying to offend anyone or start an argument, but I would like to see some healthy debate on the issue. I think we can be adults and not get everyone's ire up. :) :) :) It is not of the silver's antibiotic properties I have doubts about per se. Rather, it is the sterility of the product generated being aerosolized and inhaled into the lungs of a person with Cf that worries me. Several members of one Cf group are really pushing the members to purchase a silver generator (which is fairly expensive btw.) But in order to generate the silver infusion the instructions include purchasing distilled water from those big gallon jugs to make the silver infusion. It's always been drilled into my head that distilled water is not sterile. It is highly disinfected. The distillation removes the minerals tap water has, but it is not labeled or certified as sterile. Which means It does not have to be packaged for sterility like sterile water. I am assuming that would make the risk of contamination either on the shelf, or once it ...
Source: Cystic Fibrosis Alternative Medicine Forum - Category: Respiratory Medicine Authors: Tags: Alternative Medicine Source Type: forums

Related Links:

Publication date: Available online 8 November 2019Source: Respiratory InvestigationAuthor(s): Lucia Vietri, Annalisa Fui, Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, Piersante Sestini, Paola Rottoli, Elena BargagliAbstractSerum amyloid A is an acute-phase protein with multiple immunological functions. Serum amyloid A is involved in lipid metabolism, inflammatory reactions, granuloma formation, and cancerogenesis. Additionally, serum amyloid A is involved in the pathogenesis of different autoimmune lung diseases. The levels of serum amyloid A has been evaluated in biological fluids of patients with different...
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
Conditions:   Bronchial Asthma;   Pulmonary Cystic Fibrosis Intervention:   Diagnostic Test: Collection of breath condensate Sponsors:   The Institute of Molecular and Translational Medicine, Czech Republic;   University Hospital Olomouc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Mucin 5B (MUC5B) has an essential role in mucociliary clearance that protects the pulmonary airways. Accordingly, knowledge of MUC5B structure and its interactions with itself and other proteins is critical to better understand airway mucus biology and improve the management of lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The role of an N-terminal multimerization domain in the supramolecular organization of MUC5B has been previously described, but less is known about its C-terminal dimerization domain. Here, using cryogenic electron microscopy (cryo-EM) and small-angle X-...
Source: Journal of Biological Chemistry - Category: Chemistry Authors: Tags: Glycobiology and Extracellular Matrices Source Type: research
Doušová T, Pohunek P Abstract BACKGROUND: Bronchial epithelial reticular basement membrane (RBM) thickening occurs in diseases with both eosinophilic [allergic bronchial asthma (AB)] and neutrophilic [cystic fibrosis (CF), primary ciliary dyskinesia (PCD)] chronic airway inflammation; however, lung function and airway remodelling relationship remains unclear. The aim of the study was to test whether ventilation inhomogeneity is related to RBM thickening. METHODS: Multiple breath washout test, endobronchial biopsy, and bronchoalveolar lavage were performed in 24 children with CF, 11 with PCD, 15...
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
We present a 23-year-old male with a history of cystic fibrosis (CF) with associated renal disease, bronchiectasis, pneumothorax, and distal intestinal obstruction syndrome admitted for CF exacerbation. Sputum culture was positive for methicillin resistant Staphylococcus aureus (MRSA). Chest imaging revealed extensive opacities in the left lung. His FEV1 during admission was 52% (baseline 70%). Allergy was consulted as inhaled vancomycin therapy was preferred, but the patient had previous vancomycin-induced reactions.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
High antibiotic utilization is an essential element of life-saving care for cystic fibrosis (CF) patients. However, adverse drug reactions (ADRs) to antibiotics occur more commonly and discrete types of ADRs may differ in CF patients compared to the general population. Characterization of documented ADRs among CF patients is needed in order understand how antibiotic utilization can be improved for CF patients.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
Allergic bronchopulmonary aspergillosis (ABPA) affects up to 15% of patients with cystic fibrosis (CF), representing a significant clinical challenge. It is especially a concern in the pediatric population given adverse effects of steroids in this population. Here we report on the use of omalizumab in the treatment of steroid-resistant ABPA in a pediatric patient with CF.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
Publication date: Available online 21 October 2019Source: International Journal of PharmaceuticsAuthor(s): Sie Huey Lee, Desmond Heng, Jeanette W.P. Teo, Frederick K.Y. Toh, Reginald B.H. TanAbstractIn respiratory and genetic disorders such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis and cystic fibrosis (CF), the lungs produce excess mucus, resulting in a thickened mass, which clogs up the airways and reduces airflow. Consequently, breathing becomes more difficult. Medications that break down the structure of mucus will be especially useful in managing the early symptoms of these diseases an...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
BackgroundChronic rhinosinusitis (CRS) is associated with bronchiectasis; however, this relationship has not been well studied in the United States (US) population. In this work we aimed to determine the prevalence of CRS among patients with bronchiectasis affiliated with a US tertiary medical center and identify which comorbid diseases are associated with the presence of CRS in patients with bronchiectasis.MethodsThis was a retrospective cohort study in which data were obtained from a large database warehouse at a tertiary care center. Patients with bronchiectasis were identified from 2007 to 2017 using diagnosis codes fr...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Researchers are developing a smart shirt that -together with a mobile app – can reliably measure breathing in healthy people while carrying out a range of everyday activities. This means they can now test out the smart shirts with patients who have chronic obstructive pulmonary disease (COPD). If successful, they hope this will allow doctors to monitor patients remotely for early signs that their condition is getting worse. The research was presented by Denise Mannée, a technical physician and PhD candidate at Radboud University Medical Centre in The Netherlands. In a release she said: "...
Source: MDDI - Category: Medical Devices Authors: Tags: Materials Digital Health Source Type: news
More News: Alternative and Complementary Therapies | Asthma | Complementary Medicine | Cystic Fibrosis | Politics | Respiratory Medicine | Study